Closing Bell: Nervgen Pharma Corp down on Wednesday (NGEN)

Today, shares of Nervgen Pharma Corp opened at $2.26 and closed at $2.27. Intraday prices ranged from a low of $2.22 to a high of $2.27.

Share prices dipped -0.44% from the previous day's close of $2.28.

During the day across North America, the TSX Composite closed -0.44% at 21516.90, the S&P 500 closed 0.25% at 5487.03, the Dow Jones Industrial Average closed 0.15% at 38834.86 and the Nasdaq Composite closed 0.03% at 17862.23.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

A total of 26,153 shares was traded during the last trading day, with total trades of 21, while having an average volume of 63,311 in the last five days.

The TSX-V market on the whole today saw 2,166 price advancers against 3,011 declines and 163 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have raised 40.12 percent in the last year, while they have dipped -15.93% this year.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $159.44 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..